A PHASE 1 STUDY OF PRE-OPERATIVE CEMIPLIMAB [REGN2810], ADMINISTERED INTRALESIONALLY, FOR PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA [CSCC] OR BASAL CELL CARCINOMA [BCC] (NCT03889912)

Regeneron R2810-ONC-1787

This trial is Currently recruiting
Registration number NCT03889912

Program & service

This trial is being run with the Specialty Medicine service, and as part of the Dermatology program.

Trial phase

Phase 1

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principle investigator

Professor Johannes S Kern

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.